R&D Systems Human LILRB3/CD85a/ILT5, Carrier-Free Recombinant Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Manufacturer: R&D Systems 9159T5050
DescriptionThe Recombinant Human LILRB3/CD85a/ILT5 Protein is derived from HEK293. The Recombinant Human LILRB3/CD85a/ILT5 Protein has been validated for the following applications: Bioactivity.
|>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining|
|<0.10 EU per 1μg of the protein by the LAL method.|
|Measured by its binding ability in a functional ELISA. When Recombinant Human LILRB3/CD85a/ILT5 is coated at 2μg/mL, Recombinant Human Angiopoietin-like 7 binds with an ED50 = 50-300ng/mL.|
|Observed M.W.: 60-69kDa, reducing conditions, Theoretical M.W.: 47kDa|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.|
|CD85 antigen-like family member A, CD85a, CD85a antigen, HL9Immunoglobulin-like transcript 5, ILT5, ILT-5, ILT5CD85a, Leukocyte immunoglobulin-like receptor 3, leukocyte immunoglobulin-like receptor subfamily B member 3, leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), LIR3, LIR3CD85A, LIR-3MGC138403, member 3, Monocyte inhibitory receptor HL9, PIRB|
|Human embryonic kidney cell, HEK293-derived Gly24-Glu443, with a C-terminal 6-His tag|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok